{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T20:48:29Z","timestamp":1772138909596,"version":"3.50.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virol J"],"published-print":{"date-parts":[[2011,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Hepatitis C Virus (HCV) genotype and viral load are two significant predictive variables knowledge of which might persuade treatment decisions. The objective of the present study was to identify the distribution of different HCV genotypes circulating in the study area and to estimate viral load in chronically HCV infected patients. Out of total 305 HCV positive patients, 177 (58%) were males and 128 (42%) were females. Frequency breakup of the HCV positive patients was 169, 69, 38 and 29 from Abbottabad, Mansehra, Haripur and Battagram districts respectively. Out of the total 305 tested serum samples, 255 (83.06%) were successfully genotyped whereas 50 (16.4%) samples were found with unclassified genotypes. Among typable genotypes, 1a accounted for 21 (6.8%) 1b for 14 (4.6%), 2a for 4 (1.31%) 3a for 166 (54.42%) and genotype 3b for (8.19%). Twenty five (8.19%) patients were infected with mixed HCV genotypes. Viral load distribution was classified into three categories based on its viral load levels such as low (&lt; 60, 0000 IU\/mL), intermediate (60,0000-80,0000 IU\/mL) and high (&gt; 80,0000 IU\/mL). The baseline HCV RNA Viral load in HCV genotype 3 infected patients was 50 (26.17%), 46 (24.08%) and 95 (49.73%) for low, intermediate and high categories respectively. For genotypes other than 3, these values for low, intermediate and high viral load categories were 50 (43.85), 35 (30.70) and 29 (25.43) respectively. Pre-treatment viral load in patients with untypable genotype was 19 (38.00%), 5 (20.00%) and 11 (44.00%) for low, intermediate and high viral load categories. Viral load distribution was also categorized sex wise; for males it was 58 (32.76%), 26 (14.68%) and 93 (52.54%) whereas for females it was 40 (31.25%), 34 (26.56%) and 54 (42.18%) for low, intermediate and high viral load respectively. In conclusion HCV genotype 3a is the most prevalent genotype circulating in Hazara Division like other parts of pakistan. Pre-treatment viral load is significantly high (p 0.014) in patients infected with HCV genotype 3 as compared to other genotypes.<\/jats:p>","DOI":"10.1186\/1743-422x-8-466","type":"journal-article","created":{"date-parts":[[2011,10,21]],"date-time":"2011-10-21T18:46:15Z","timestamp":1319222775000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Determination of HCV genotypes and viral loads in chronic HCV infected patients of Hazara Pakistan"],"prefix":"10.1186","volume":"8","author":[{"given":"Amjad","family":"Ali","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad","family":"Nisar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Habib","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nausheen","family":"Saif","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad","family":"Idrees","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad A","family":"Bajwa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,10,9]]},"reference":[{"key":"1565_CR1","doi-asserted-by":"publisher","first-page":"3173","DOI":"10.1099\/vir.0.80401-0","volume":"85","author":"P Simmonds","year":"2004","unstructured":"Simmonds P: Genetic diversity and evolution of hepatitis C virus--15 years on. J Gen Virol 2004, 85: 3173-3188. 10.1099\/vir.0.80401-0","journal-title":"J Gen Virol"},{"key":"1565_CR2","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1053\/bega.1999.0071","volume":"14","author":"T Poynard","year":"2000","unstructured":"Poynard T, Ratziu V, Benhamou Y, Opolon P, Cacoub P, Bedossa P: Natural history of HCV infection. Best Pract Res Clin Gastroenterol 2000, 14: 211-228. 10.1053\/bega.1999.0071","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"1565_CR3","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.meegid.2010.04.012","volume":"10","author":"S Butt","year":"2010","unstructured":"Butt S, Idrees M, Akbar H, Rehman I, Awan Z, Afzal S: The changing epidemiology pattern and frequency distribution of hepatitis C virus in Pakistan. Infect Genet Evol 2010, 10: 595-600. 10.1016\/j.meegid.2010.04.012","journal-title":"Infect Genet Evol"},{"key":"1565_CR4","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/1743-422X-8-105","volume":"8","author":"S Khan","year":"2011","unstructured":"Khan S, Attaullah S, Ayaz S, N Khan S, Shams S, Ali I, Bilal M, Siraj S: Molecular Epidemiology of HCV among Health Care Workers of Khyber Pakhtunkhwa . Virology Journal 2011, 8: 105. 10.1186\/1743-422X-8-105","journal-title":"Virology Journal"},{"key":"1565_CR5","first-page":"8","volume-title":"BMC Infect Dis","author":"M Idrees","year":"2008","unstructured":"Idrees M, Riazuddin S: Frequency distribution of hepatitis C virus genotypes in different geographical regions of Pakistan and their possible routes of transmission. BMC Infect Dis 2008, 8-69."},{"key":"1565_CR6","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1111\/j.1751-2980.2008.00329.x","volume":"9","author":"M Idrees","year":"2008","unstructured":"Idrees M, Lal A, Naseem M, Khalid M: High prevalence of hepatitis C virus infection in the largest province of Pakistan. J Dig Dis 2008, 9: 95-103. 10.1111\/j.1751-2980.2008.00329.x","journal-title":"J Dig Dis"},{"key":"1565_CR7","doi-asserted-by":"publisher","first-page":"2451","DOI":"10.1073\/pnas.88.6.2451","volume":"88","author":"QL Choo","year":"1991","unstructured":"Choo QL, Richman KH, Han JH, Berger K, Lee C, Dong C, Gallegos C, Coit D, Medina-Selby R, Barr PJ, Weiner A, Bradley DW, Kuo G, Houghton M: Genetic organization and diversity of the hepatitis C virus. Proc Natl Acad Sci USA 1991, 88: 2451-2455. 10.1073\/pnas.88.6.2451","journal-title":"Proc Natl Acad Sci USA"},{"key":"1565_CR8","doi-asserted-by":"publisher","first-page":"10292","DOI":"10.1073\/pnas.88.22.10292","volume":"88","author":"G Inchauspe","year":"1991","unstructured":"Inchauspe G, Zebedee S, Lee DH, Sugitani M, Nasoff M, Prince AM: Genomic structure of the human prototype strain H of hepatitis C virus: comparison with American and Japanese isolates. Proc Natl Acad Sci USA 1991, 88: 10292-20296. 10.1073\/pnas.88.22.10292","journal-title":"Proc Natl Acad Sci USA"},{"key":"1565_CR9","first-page":"1253","volume-title":"Fields Virology","author":"SM Lemon","year":"2007","unstructured":"Lemon SM, Walker CM, Alter MJ, Yi M: Hepatitis C virus. In Fields Virology. Lippincot Williams and Wilkins, Philadelpia; 2007:1253-1304."},{"key":"1565_CR10","doi-asserted-by":"publisher","first-page":"458","DOI":"10.4065\/71.5.458","volume":"71","author":"NN Zein","year":"1996","unstructured":"Zein NN, Persing D: Hepatitis C genotypes: current trends and future implications. Mayo Clin Proc 1996, 71: 458-462. 10.4065\/71.5.458","journal-title":"Mayo Clin Proc"},{"key":"1565_CR11","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S1665-2681(19)31676-X","volume":"9","author":"R Jimenez-M","year":"2010","unstructured":"Jimenez-M R, Urbie-S F, Guillen L-P, Garza C-L, Hernandez Ca-G: Distribution of HCV genotypes and HCV RNA viral load in different geographical regions of Mexico. Annals Hepatology 2010, 9: 33-39.","journal-title":"Annals Hepatology"},{"key":"1565_CR12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/135965350501000118","volume":"10","author":"HJ Hanatyszyn","year":"2005","unstructured":"Hanatyszyn HJ: Chronic hepatitis and genotyping: the clinical significance of determining HCV genotypes. Antiviral Ther 2005, 10: 1-11.","journal-title":"Antiviral Ther"},{"key":"1565_CR13","doi-asserted-by":"publisher","first-page":"7914","DOI":"10.1128\/JVI.77.14.7914-7923.2003","volume":"77","author":"D Candotti","year":"2003","unstructured":"Candotti D, Temple J, Sarkodie F, Allain JP: Frequent recovery and broad genotype 2 diversity characterize hepatitis C virus infection in Ghana, West Africa. J Virol 2003, 77: 7914-7923. 10.1128\/JVI.77.14.7914-7923.2003","journal-title":"J Virol"},{"key":"1565_CR14","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.1099\/vir.0.19240-0","volume":"84","author":"J Ndjomou","year":"2003","unstructured":"Ndjomou J, Pybus OG, Matz B: Phylogenetic analysis of hepatitis C virus isolates indicates a unique pattern of endemic infection in Cameroon. J Gen Virol 2003, 84: 2333-2341. 10.1099\/vir.0.19240-0","journal-title":"J Gen Virol"},{"key":"1565_CR15","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1099\/0022-1317-81-6-1485","volume":"81","author":"K Abid","year":"2000","unstructured":"Abid K, Quadri R, Veuthey AL, Hadengue A, Negro F: A novel hepatitis C virus (HCV) subtype from Somalia and its classification into HCV clade 3. J Gen Virol 2000, 81: 1485-1493.","journal-title":"J Gen Virol"},{"key":"1565_CR16","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1093\/infdis\/171.6.1607","volume":"171","author":"JM Pawlotsky","year":"1995","unstructured":"Pawlotsky JM, Tsakiris L, Roudot-Thoraval F, Pellet C, Stuyver L, Duval J, Dhumeaux D: Relationship between hepatitis C virus genotypes and sources of infection in patients with chronic hepatitis C. J Infect Dis 1995, 171: 1607-1610. 10.1093\/infdis\/171.6.1607","journal-title":"J Infect Dis"},{"issue":"Pt 6","key":"1565_CR17","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1099\/0022-1317-78-6-1341","volume":"78","author":"RW Chamberlain","year":"1997","unstructured":"Chamberlain RW, Adams N, Saeed AA, Simmonds P, Elliott RM: Complete nucleotide sequence of a type 4 hepatitis C virus variant, the predominant genotype in the Middle East. J Gen Virol 1997,78(Pt 6):1341-1347.","journal-title":"J Gen Virol"},{"key":"1565_CR18","first-page":"7250","volume-title":"Journal of Viral Hepatitis","author":"C Trepo","year":"2000","unstructured":"Trepo C: Genotype and viral load as prognostic indicators in the treatment of hepatitis C. Journal of Viral Hepatitis 2000, 7250-257."},{"key":"1565_CR19","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1002\/hep.1840160203","volume":"16","author":"K Yoshioka","year":"1992","unstructured":"Yoshioka K, Kakumu S, Wakita T: Detection of hepatitis C virus by polymerase chain reaction and response to interferon-a therapy: relationship to genotypes of hepatitis C virus. Hepatology 1992, 16: 293-299. 10.1002\/hep.1840160203","journal-title":"Hepatology"},{"key":"1565_CR20","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1002\/hep.1840220406","volume":"22","author":"M Martinot-Peignoux","year":"1995","unstructured":"Martinot-Peignoux M, Marcellin P, Pouteau M: Pretreatment serum hepatitic C virus RNA levels and hepatitis C virus genotype are the main and independent prognostic factors of sustained response to interferon alfa therapy in chronic hepatitis C. Hepatology 1995, 22: 1050-1056.","journal-title":"Hepatology"},{"key":"1565_CR21","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3109\/00365549709008658","volume":"29","author":"H Bell","year":"1997","unstructured":"Bell H, Hellum K, Harthug S: Genotype, viral load and age as independent predictors of treatment outcome of interferon-\u03b1 2a treatment in patients with chronic hepatitis C. Scand J Infect Dis 1997, 29: 17-22. 10.3109\/00365549709008658","journal-title":"Scand J Infect Dis"},{"key":"1565_CR22","volume-title":"HCV genotypes and Quasipcies. Hepatitis C support project","author":"A Franciscus","year":"2006","unstructured":"Franciscus A: HCV genotypes and Quasipcies. Hepatitis C support project.2006. [http:\/\/www.hcvadvocate.org]"},{"key":"1565_CR23","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1053\/j.gastro.2005.05.008","volume":"129","author":"M Von Wagner","year":"2005","unstructured":"Von Wagner M, Huber M, Berg T: Peginterferon-alpha-2a (40KD) and ribavirin for 16 or 24 weeks in patients with genotype 2 or 3 chronic hepatitis C. Gastroenterology 2005, 129: 522-7.","journal-title":"Gastroenterology"},{"key":"1565_CR24","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1002\/hep.20467","volume":"40","author":"O Dalgard","year":"2004","unstructured":"Dalgard O, Bjoro K, Hellum KB: Treatment with pegylated interferon and ribavarin in HCV infection with genotype 2 or 3 for 14 weeks: a pilot study. Hepatology 2004, 40: 1260-5. 10.1002\/hep.20467","journal-title":"Hepatology"},{"key":"1565_CR25","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1023\/A:1018874910195","volume":"43","author":"J Hayashi","year":"1998","unstructured":"Hayashi J, Kawakami Y, Nabeshima A: Comparison of HCV RNA levels by branched DNA probe assay and by competitive polymerase chain reaction to predict effectiveness of interferon treatment for patients with chronic hepatitis C virus. Dig Dis Sci 1998, 43: 384-391. 10.1023\/A:1018874910195","journal-title":"Dig Dis Sci"},{"key":"1565_CR26","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1111\/j.1440-1746.1997.tb00468.x","volume":"12","author":"S Kakumu","year":"1997","unstructured":"Kakumu S, Aiyama T, Okumura A, Iwata K, Ishikawa T, Yoshioka K: Earlier loss of hepatitis C virus RNA in interferon therapy can predict a long-term response in chronic hepatitis C. J Gastroenterol Hepatol 1997, 12: 468-472. 10.1111\/j.1440-1746.1997.tb00468.x","journal-title":"J Gastroenterol Hepatol"},{"key":"1565_CR27","first-page":"76","volume":"62","author":"JM Vrolijk","year":"2004","unstructured":"Vrolijk JM, de Knegt RJ, Veldt BJ, Orlent H, Schalm SW: The treatment of hepatitis C: history, presence and future. Neth J Med 2004, 62: 76-82.","journal-title":"Neth J Med"},{"key":"1565_CR28","doi-asserted-by":"publisher","first-page":"4321","DOI":"10.3748\/wjg.v16.i34.4321","volume":"16","author":"W Ahmad","year":"2010","unstructured":"Ahmad W, Ijaz B, Javed TF, Jahan S, Shahid I, Khan FM, Hassan S: HCV genotype distribution and possible transmission risks in Lahore, Pakistan. World J Gastroenterol 2010, 16: 4321-4328. 10.3748\/wjg.v16.i34.4321","journal-title":"World J Gastroenterol"},{"key":"1565_CR29","first-page":"1","volume":"203","author":"A Ali","year":"2010","unstructured":"Ali A, Ahmed H, Idrees M: Molecular epidemiology of Hepatitis C virus genotypes in Khyber Pakhtoonkhaw of Pakistan. Virol J 2010, 203: 1-7.","journal-title":"Virol J"},{"key":"1565_CR30","first-page":"8","volume-title":"Virology Journal","author":"M Inamullah Idrees","year":"2011","unstructured":"Inamullah Idrees M, Ahmed H, Ghafoor S, Ali M, Ali L, Ahmed A: Hepatitis C virus genotype circulating in district Swat of Khyber Pakhtoonkhaw , Pakistan. Virology Journal 2011, 8-16."},{"key":"1565_CR31","first-page":"46","volume":"40","author":"M Idrees","year":"2001","unstructured":"Idrees M: Common genotypes of hepatitis C virus present in Pakistan. Pak J Med Res 2001, 40: 46-49.","journal-title":"Pak J Med Res"},{"key":"1565_CR32","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.jviromet.2008.03.001","volume":"150","author":"M Idrees","year":"2008","unstructured":"Idrees M: Development of an improved HCV Genotyping Assay for the Detection of Common Genotypes and subtypes in Pakistan. J Virol Meth 2008, 150: 50-56. 10.1016\/j.jviromet.2008.03.001","journal-title":"J Virol Meth"},{"key":"1565_CR33","first-page":"50","volume-title":"Mansehra-an introduction, science-religion Dialogue","author":"M Ghulam","year":"2003","unstructured":"Ghulam M: Mansehra-an introduction, science-religion Dialogue. 2003, 20: 50-61."},{"key":"1565_CR34","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1186\/1743-422X-7-317","volume":"7","author":"AH Elasifer","year":"2010","unstructured":"Elasifer AH, Agnnyia YM, Al-Alagi BA, Daw MA: Epidemiological manifestations of hepatitis C virus genotypes and its association with potential risk factors among Libyan patients. Virology Journal 2010, 7: 317. 10.1186\/1743-422X-7-317","journal-title":"Virology Journal"},{"key":"1565_CR35","first-page":"11","volume":"15","author":"N Muhammad","year":"2005","unstructured":"Muhammad N, Jan MA: Frequency of hepatitis \"C\" in Buner, NWFP. J Coll Physicians Surg Pak 2005, 15: 11-14.","journal-title":"J Coll Physicians Surg Pak"},{"key":"1565_CR36","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1479-0556-9-2","volume":"9","author":"I Rehman","year":"2011","unstructured":"Rehman I, Idrees M, Ali M, Ali L, Butt S, Hussain A, Akbar H, Afzal S: Hepatitis C virus genotype 3a with phylogenetically distinct origin is circulating in Pakistan. Genetic Vaccines and Therapy 2011, 9: 2. 10.1186\/1479-0556-9-2","journal-title":"Genetic Vaccines and Therapy"},{"key":"1565_CR37","volume-title":"Mol Biol Rep","author":"A Sarwat","year":"2008","unstructured":"Sarwat A, Naeem M, Hussain A, Kakar N, Babar ME, Ahmad J: Prevalence of hepatitis C virus (HCV) genotypes in Balochistan. Mol Biol Rep 2008."},{"key":"1565_CR38","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.ijid.2007.07.003","volume":"12","author":"I Altuglu","year":"2008","unstructured":"Altuglu I, Soyler I, Ozacar T, Erensoy S: Distribution of hepatitis C virus genotypes in patients with chronic hepatitis C infection in Western Turkey. Int J Infect Dis 2008, 12: 239-244. 10.1016\/j.ijid.2007.07.003","journal-title":"Int J Infect Dis"},{"key":"1565_CR39","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1053\/jhep.2003.50157","volume":"37","author":"A Chowdhury","year":"2003","unstructured":"Chowdhury A, Santra A, Chaudhuri S, Dhali GK, Chaudhuri S, Maity SG, Naik TN, Bhattacharya SK, Mazumder DN: Hepatitis C virus infection in the general population: a community-based study in West Bengal, India. Hepatology 2003, 37: 802-809. 10.1053\/jhep.2003.50157","journal-title":"Hepatology"},{"issue":"3","key":"1565_CR40","first-page":"135","volume":"58","author":"T Shinji","year":"2004","unstructured":"Shinji T, Kyaw Y, Gokan K, Tanaka Y, Ochi K: Analysis of HCV genotypes from blood donors shows three new HCV types 6 subgroups exist in Myanmar. Acta Med Okayama 2004,58(3):135-42.","journal-title":"Acta Med Okayama"},{"key":"1565_CR41","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1099\/0022-1317-76-9-2329","volume":"76","author":"H Tokita","year":"1995","unstructured":"Tokita H, Okamoto H, Luengrojanakul P, Vareesangthip K, Chainuvati T, Iizuka H, Tsuda F, Miyakawa Y, Mayumi M: Hepatitis C virus variants from Thailand classifiable into five novel genotypes in the sixth (6b), seventh (7c, 7d) and ninth (9b, 9c) major genetic groups. J Gen Virol 1995, 76: 2329-2335. 10.1099\/0022-1317-76-9-2329","journal-title":"J Gen Virol"},{"key":"1565_CR42","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1002\/hep.510270433","volume":"27","author":"S Zeuzem","year":"1998","unstructured":"Zeuzem S, Lee JH, Franke A: Quantifcation of the initial decline of serum hepatitis C virus RNA and response to interferon alfa. Hepatology 1998, 27: 1149-1156. 10.1002\/hep.510270433","journal-title":"Hepatology"},{"key":"1565_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0166-3542(03)00088-3","volume":"59","author":"JM Pawlotsky","year":"2003","unstructured":"Pawlotsky JM: Mechanism of antiviral treatment efficacy and failure in chronic hepatitis C. Antiviral Res 2003, 59: 1-11. 10.1016\/S0166-3542(03)00088-3","journal-title":"Antiviral Res"}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1743-422X-8-466.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,10]],"date-time":"2023-06-10T17:37:02Z","timestamp":1686418622000},"score":1,"resource":{"primary":{"URL":"https:\/\/virologyj.biomedcentral.com\/articles\/10.1186\/1743-422X-8-466"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10,9]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["1565"],"URL":"https:\/\/doi.org\/10.1186\/1743-422x-8-466","relation":{},"ISSN":["1743-422X"],"issn-type":[{"value":"1743-422X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,10,9]]},"assertion":[{"value":"21 July 2011","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2011","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2011","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"466"}}